Phil Englert of Health-ISAC Explains Risk Controls for Evolving AI Healthcare Tools The Food and Drug Administration’s draft guidance for artificial intelligence-enabled medical devices reflects a major change in how regulators address software that changes over time. The framework recognizes AI’s ability to evolve while emphasizing patient safety, transparency and accountability, said Phil Englert, vice […]
The post How FDA’s Draft Guidance Shapes AI Medical Device Safety appeared first on Health-ISAC - Health Information Sharing and Analysis Center.